Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial
OftalmologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Clinical therapeutics
- Publicado em
- 11 ago 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial
Gail L Torkildsen, Guruprasad R Pattar, Gary Jerkins, Kristen Striffler, Jeffrey Nau
Descritores MeSH
- Receptors, Nicotinic
- Dry Eye Syndromes
- Double-Blind Method
- Humans
- Ophthalmic Solutions
- Fluorescein
- Varenicline
- Nasal Sprays
- Adult
Veja também
Estudos relacionados
- Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The ONSET-2 Phase 3 Randomized Trial
- Efficacy of bilateral OC-01 (varenicline solution) nasal spray in alleviating signs and symptoms of dry eye disease: A systematic review
- Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease
- Safety, adherence and discontinuation in varenicline solution nasal spray clinical trials for dry eye disease